ADDRESS-2 is supporting a study to assess the safety of a new “type 1 diabetes vaccine” designed to stop the immune system from attacking insulin-producing beta cells.
Assessment of a new “type 1 diabetes vaccine” to help preserve insulin production
ADDRESS-2 type 1 diabetes
Supporting type 1 diabetes research
Month: October 2017